- Home
- NSYS vs LGVN Comparison
NSYS vs LGVN Comparison
Compare NSYS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSYS
- LGVN
- Stock Information
- Founded
- NSYS 1981
- LGVN 2014
- Country
- NSYS United States
- LGVN United States
- Employees
- NSYS N/A
- LGVN N/A
- Industry
- NSYS Industrial Machinery/Components
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- NSYS Technology
- LGVN Health Care
- Exchange
- NSYS Nasdaq
- LGVN Nasdaq
- Market Cap
- NSYS 22.3M
- LGVN 16.6M
- IPO Year
- NSYS N/A
- LGVN 2021
- Fundamental
- Price
- NSYS $9.06
- LGVN $0.83
- Analyst Decision
- NSYS
- LGVN Strong Buy
- Analyst Count
- NSYS 0
- LGVN 3
- Target Price
- NSYS N/A
- LGVN $6.33
- AVG Volume (30 Days)
- NSYS 5.2K
- LGVN 2.0M
- Earning Date
- NSYS 08-07-2025
- LGVN 08-13-2025
- Dividend Yield
- NSYS N/A
- LGVN N/A
- EPS Growth
- NSYS N/A
- LGVN N/A
- EPS
- NSYS N/A
- LGVN N/A
- Revenue
- NSYS $117,597,000.00
- LGVN $2,073,000.00
- Revenue This Year
- NSYS N/A
- LGVN N/A
- Revenue Next Year
- NSYS N/A
- LGVN $10.78
- P/E Ratio
- NSYS N/A
- LGVN N/A
- Revenue Growth
- NSYS N/A
- LGVN 68.67
- 52 Week Low
- NSYS $7.25
- LGVN $0.63
- 52 Week High
- NSYS $13.90
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- NSYS 56.89
- LGVN 36.37
- Support Level
- NSYS $8.05
- LGVN $0.77
- Resistance Level
- NSYS $9.74
- LGVN $0.82
- Average True Range (ATR)
- NSYS 0.24
- LGVN 0.07
- MACD
- NSYS 0.08
- LGVN 0.01
- Stochastic Oscillator
- NSYS 42.86
- LGVN 58.09
About NSYS Nortech Systems Incorporated
Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.